arrow
R

Ruizhan Tong

sichuan university
H指数:14
被引数:1,329

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis

SBRT嵌入低剂量RT联合αPD-1(免疫-日食放疗,iERT)通过IFN-I/NK/DC轴诱导巨块肿瘤的CD8+ T细胞免疫

2026-07-080
OAAI
Dual-Targeting CD133/PD-L1 CAR-T plus αPD-1 Overcomes Immunosuppressive Microenvironment and Enhanced by Radiation Pre-conditioning through Induction of a Tissue-resident Memory Phenotype

双靶点CD133/PD-L1 CAR-T联合αPD-1克服免疫抑制微环境,并通过诱导组织驻留记忆表型得到辐射预处理的增强

2026-01-100
PRE
Stimulator of Interferon Genes Agonist Synergistically Amplifies Programmed Cell Death Protein-1 Blockade and Radiation-Induced Systemic Antitumor Responses via Tumor Microenvironment Enrichment

干扰素基因刺激因子激动剂通过肿瘤微环境富集,协同增强程序性细胞死亡蛋白-1阻断和辐射诱导的系统抗肿瘤反应。

2025-04-170
PRE
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
MED
IF11.8
2024-10-013
OAAI
Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer

低剂量放射治疗对小鼠和非小细胞肺癌患者对大分割放射治疗和Anti-PD1的远视反应的影响

2020-09-01103
PREAI
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer (vol 23, pg 831, 2020)
2020-06-185
OAAI
Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
2020-04-27388
PREAI